Medpace President Resigns; CEO August Troendle Temporarily Reassumes Role
summarizeSummary
Medpace Holdings announced the resignation of its President, Jesse Geiger, effective May 31, 2026, with CEO August Troendle temporarily reassuming the role, alongside formalizing strong Q1 results and positive 2026 guidance.
check_boxKey Events
-
President Resigns
Jesse Geiger notified the company of his intent to resign as President and retire effective May 31, 2026. The company stated this departure is not the result of any disagreement.
-
CEO Assumes Interim Role
Effective upon Mr. Geiger's resignation, CEO August Troendle will temporarily reassume the role of President until a successor is appointed.
-
Strong Q1 Financial Results Formalized
The company reported Q1 2026 revenue of $706.6 million, a 26.5% increase year-over-year, and diluted GAAP EPS of $4.28. This formalizes results previously reported by news outlets on April 22, 2026.
-
Positive 2026 Guidance Formalized
Medpace provided full-year 2026 revenue guidance of $2.755 billion to $2.855 billion and diluted GAAP EPS guidance of $16.68 to $17.50. This formalizes guidance previously reported by news outlets on April 22, 2026.
auto_awesomeAnalysis
This 8-K reports the resignation of President Jesse Geiger, effective May 31, 2026. While the company states the departure is not due to any disagreement, the resignation of a key executive is a notable event. CEO August Troendle will temporarily take on the President role, providing continuity during the transition. The filing also formalizes the company's strong first-quarter financial results and positive full-year 2026 guidance, which were previously reported by news outlets.
At the time of this filing, MEDP was trading at $420.01 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $14.5B. The 52-week trading range was $250.05 to $628.92. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.